“Human myeloma RPMI8226 cells and normal cells have different sensitivity to bisilicate silver nanoparticles in vitro” (2021) Voprosy onkologii, 67(5), pp. 724–730. doi:10.37469/0507-3758-2021-67-5-724-730.